Oura, the maker of the popular health tracking smart ring, has postponed an initial public offering that would have raised up to 2.2 billion dollars, even as investor demand for the stock appeared unusually strong.
The company had planned to sell 50 million shares priced between 40 and 44 dollars apiece, a range that would have valued Oura at roughly 15.6 billion dollars on a fully diluted basis. According to people familiar with the offering, orders for the deal came in at about four times the number of shares available, a level of demand that would typically support moving forward with a listing rather than pulling back.
A Strong Business Pauses Anyway
Oura's underlying business has shown little sign of trouble. The company's newest device, the Oura Ring 5, has been well received since launch, and its paying membership base grew to 5.7 million from 5 million at the end of June. Revenue is projected to climb roughly 90 percent year over year for the current fiscal year, and the proposed IPO valuation would have marked a significant jump from the 11 billion dollar price tag investors placed on the company roughly a year earlier during a 900 million dollar private funding round.






